Literature DB >> 29845991

Exploiting the biomolecular corona: pre-coating of nanoparticles enables controlled cellular interactions.

Johanna Simon1, Laura K Müller2, Maria Kokkinopoulou2, Ingo Lieberwirth2, Svenja Morsbach2, Katharina Landfester2, Volker Mailänder1.   

Abstract

Formation of the biomolecular corona ultimately determines the successful application of nanoparticles in vivo. Adsorption of biomolecules such as proteins is an inevitable process that takes place instantaneously upon contact with physiological fluid (e.g. blood). Therefore, strategies are needed to control this process in order to improve the properties of the nanoparticles and to allow targeted drug delivery. Here, we show that the design of the protein corona by a pre-formed protein corona with tailored properties enables targeted cellular interactions. Nanoparticles were pre-coated with immunoglobulin depleted plasma to create and design a protein corona that reduces cellular uptake by immune cells. It was proven that a pre-formed protein corona remains stable even after nanoparticles were re-introduced to plasma. This opens up the great potential to exploit protein corona formation, which will significantly influence the development of novel nanomaterials.

Year:  2018        PMID: 29845991     DOI: 10.1039/c8nr03331e

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  21 in total

1.  Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds.

Authors:  Flavia Fontana; Raquél Bartolo; Hélder A Santos
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function.

Authors:  Rebecca L Pinals; Linda Chio; Francis Ledesma; Markita P Landry
Journal:  Analyst       Date:  2020-07-01       Impact factor: 4.616

Review 3.  Nanoparticle Interactions with the Tumor Microenvironment.

Authors:  Yanyan Huai; Md Nazir Hossen; Stefan Wilhelm; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Bioconjug Chem       Date:  2019-09-05       Impact factor: 4.774

4.  The effect of drug loading and multiple administration on the protein corona formation and brain delivery property of PEG-PLA nanoparticles.

Authors:  Yuyun Tang; Jinchao Gao; Tao Wang; Qian Zhang; Antian Wang; Meng Huang; Renhe Yu; Hongzhuan Chen; Xiaoling Gao
Journal:  Acta Pharm Sin B       Date:  2021-09-30       Impact factor: 14.903

5.  Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part II: In vitro and in vivo Kinetics Study.

Authors:  Aya Ahmed Sebak; Iman Emam Omar Gomaa; Aliaa Nabil ElMeshad; Mahmoud Hussien Farag; Ulrike Breitinger; Hans-Georg Breitinger; Mahmoud Hashem AbdelKader
Journal:  Int J Nanomedicine       Date:  2020-11-30

Review 6.  Biocompatibility of nanomaterials and their immunological properties.

Authors:  Themis R Kyriakides; Arindam Raj; Tiffany H Tseng; Hugh Xiao; Ryan Nguyen; Farrah S Mohammed; Saiti Halder; Mengqing Xu; Michelle J Wu; Shuozhen Bao; Wendy C Sheu
Journal:  Biomed Mater       Date:  2021-03-11       Impact factor: 3.715

7.  The Possible Role of Sex As an Important Factor in Development and Administration of Lipid Nanomedicine-Based COVID-19 Vaccine.

Authors:  Elisabetta Vulpis; Francesca Giulimondi; Luca Digiacomo; Alessandra Zingoni; Reihaneh Safavi-Sohi; Shahriar Sharifi; Giulio Caracciolo; Morteza Mahmoudi
Journal:  Mol Pharm       Date:  2021-05-13       Impact factor: 4.939

8.  Interplay of protein corona and immune cells controls blood residency of liposomes.

Authors:  Francesca Giulimondi; Luca Digiacomo; Daniela Pozzi; Sara Palchetti; Elisabetta Vulpis; Anna Laura Capriotti; Riccardo Zenezini Chiozzi; Aldo Laganà; Heinz Amenitsch; Laura Masuelli; Giovanna Peruzzi; Morteza Mahmoudi; Isabella Screpanti; Alessandra Zingoni; Giulio Caracciolo
Journal:  Nat Commun       Date:  2019-08-15       Impact factor: 14.919

9.  Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part I: In vitro Release and Intracellular Uptake Perspective.

Authors:  Aya Ahmed Sebak; Iman Emam Omar Gomaa; Aliaa Nabil ElMeshad; Mahmoud Hussien Farag; Ulrike Breitinger; Hans-Georg Breitinger; Mahmoud Hashem AbdelKader
Journal:  Int J Nanomedicine       Date:  2020-11-10

10.  Artificial Protein Coronas Enable Controlled Interaction with Corneal Epithelial Cells: New Opportunities for Ocular Drug Delivery.

Authors:  Carlo Astarita; Sara Palchetti; Mina Massaro-Giordano; Marina Di Domenico; Francesco Petrillo; Silvia Boffo; Giulio Caracciolo; Antonio Giordano
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.